Showing results (581-590 of 712) with videos related to
Sort By:
Pageof 72
JAMA Network Open|September 24, 2024
Preconception HbA1c Levels in Adolescents and Young Adults and Adverse Birth OutcomesKatharine J McCarthy, Shelley H Liu, Joseph Kennedy, et al.Atherosclerosis|June 15, 2024
Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetesAnouk G Groenen, Benedek Halmos, Isabelle A van Zeventer, et al.Journal of Cancer Survivorship : Research and Practice|November 5, 2017
Randomized trial of a clinic-based weight loss intervention in cancer survivorsJustin C Brown, Rachel L Yung, Anita Gobbie-Hurder, et al.Frontiers in Neurology|February 21, 2012
High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injuryCharles W Wilkinson, Kathleen F Pagulayan, Eric C Petrie, et al.Annals of Surgical Oncology|April 24, 2014
Sentinel lymph node biopsy in pregnant women with breast cancerAdrienne B Gropper, Katherina Zabicki Calvillo, Laura Dominici, et al.American Journal of Perinatology|August 21, 2023
Predictors and Trends in First-Trimester Hemoglobin A1c Screening in New York City, 2009 to 2017Luciana Vieira, Katharine McCarthy, Shelley H Liu, et al.Nucleic Acids Research|April 23, 2025
DirectHRD enables sensitive scar-based classification of homologous recombination deficiencyRuolin Liu, Eugenia Roberts, Heather A Parsons, et al.Journal of the Royal Society, Interface|July 20, 2006
Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patientsN M Ferguson, C A Donnelly, J Hooper, et al.Journal of Medicinal Chemistry|March 14, 2007
Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonistsNigel P Dolman, Julia C A More, Andrew Alt, et al.Breast Cancer Research and Treatment|February 6, 2025
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast cancer: a discrete choice survey studyErica L Mayer, Mary Lou Smith, Annie Guérin, et al.Pageof 72